Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

GLUE US Equity

Monte Rosa Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1826457 · FY ends Dec 31
$15.77
+0.74 (+4.92%)
USD · as of 2026-08-19 · marketstack
11 8-K filings · 4 13D · 15 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by MONTANOVA CAPITAL, LLCsec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by Vestal Point Capital, LPsec.gov ↗
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-0813G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2026-07-0613D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by New Enterprise Associates 17, L.P.sec.gov ↗
2026-06-118-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by TCG Crossover GP II, LLCsec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BAKER BROS. ADVISORS LPsec.gov ↗
2026-05-1513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-2213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Dimension Capital I, L.P.sec.gov ↗
2026-03-1913D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by New Enterprise Associates 17, L.P.sec.gov ↗
2026-03-178-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BIOTECHNOLOGY VALUE FUND L Psec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BAKER BROS. ADVISORS LPsec.gov ↗
2026-02-108-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-01-2113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Dimension Capital I, L.P.sec.gov ↗
2026-01-098-K 8.01Other eventssec.gov ↗
2026-01-098-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-01-0913D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Versant Venture Capital VI, L.P.sec.gov ↗
2026-01-078-K 8.01Other eventssec.gov ↗
2026-01-078-K 8.01Other eventssec.gov ↗
2026-01-078-K 7.01Regulation FD disclosuresec.gov ↗
2025-12-168-K 8.01Other eventssec.gov ↗
2025-12-168-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by PRICE T ROWE ASSOCIATES INC /MD/sec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Avoro Capital Advisors LLCsec.gov ↗
2025-11-1213D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Versant Venture Capital VI, L.P.sec.gov ↗
2025-11-068-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-3113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by VANGUARD GROUP INCsec.gov ↗
2025-10-1713GSchedule 13G filed — ≥5% beneficial owner (passive) · by TCG Crossover GP II, LLCsec.gov ↗
2025-10-0313GSchedule 13G filed — ≥5% beneficial owner (passive) · by Dimension Capital I, L.P.sec.gov ↗
2025-09-158-K 7.01Regulation FD disclosuresec.gov ↗
2025-09-158-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-15

Every row is a filed document, checked against its EDGAR index.